Disease
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 11, 2026 · JOURNAL ARTICLE
Cancer Biology & Therapy
This is a narrative review synthesizing mechanistic evidence on platelet-tumor interactions without reporting primary experimental or clinical data, clinical endpoints, or quantified effect sizes.
MAY 19, 2026 · JOURNAL ARTICLE
Cell Cycle
This is a mechanistic cell and tissue study demonstrating that UBE2C knockdown suppresses pancreatic cancer cell behavior through PI3K/Akt/mTOR pathway inhibition, with reversal by pathway activator SC79, but lacks clinical trial data, human efficacy endpoints, or effect sizes with confidence intervals.